Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Superoxide Dismutase | 23 | 2013 | 225 | 2.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 23 | 2019 | 504 | 1.680 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 4 | 2024 | 44 | 1.280 |
Why?
|
| Paralysis, Hyperkalemic Periodic | 6 | 2020 | 8 | 1.230 |
Why?
|
| Mutation | 23 | 2019 | 2609 | 1.090 |
Why?
|
| Muscle, Skeletal | 11 | 2022 | 741 | 0.990 |
Why?
|
| Sodium Channels | 7 | 2012 | 25 | 0.860 |
Why?
|
| Catatonia | 1 | 2023 | 5 | 0.850 |
Why?
|
| Leukoencephalopathies | 1 | 2023 | 25 | 0.830 |
Why?
|
| RNA-Binding Protein FUS | 5 | 2019 | 53 | 0.760 |
Why?
|
| Motor Neuron Disease | 5 | 2008 | 28 | 0.710 |
Why?
|
| Myotonia | 3 | 2008 | 3 | 0.550 |
Why?
|
| Superoxide Dismutase-1 | 14 | 2016 | 143 | 0.470 |
Why?
|
| Muscle Contraction | 3 | 2020 | 202 | 0.460 |
Why?
|
| Muscle Fatigue | 1 | 2012 | 48 | 0.380 |
Why?
|
| Potassium | 4 | 2020 | 101 | 0.370 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2011 | 19 | 0.360 |
Why?
|
| Paralyses, Familial Periodic | 4 | 1999 | 4 | 0.350 |
Why?
|
| Metals | 4 | 2009 | 65 | 0.350 |
Why?
|
| Motor Neurons | 7 | 2019 | 212 | 0.340 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2009 | 265 | 0.340 |
Why?
|
| Axonal Transport | 4 | 2013 | 32 | 0.320 |
Why?
|
| Mutation, Missense | 4 | 2015 | 186 | 0.320 |
Why?
|
| Animals | 32 | 2023 | 20661 | 0.300 |
Why?
|
| Copper | 3 | 2007 | 51 | 0.290 |
Why?
|
| Zinc | 3 | 2005 | 92 | 0.280 |
Why?
|
| Point Mutation | 5 | 2005 | 166 | 0.270 |
Why?
|
| Disulfides | 2 | 2009 | 64 | 0.270 |
Why?
|
| Mice | 19 | 2023 | 10844 | 0.270 |
Why?
|
| Humans | 42 | 2024 | 63459 | 0.260 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2020 | 94 | 0.260 |
Why?
|
| Amino Acid Substitution | 7 | 2008 | 240 | 0.250 |
Why?
|
| Homeodomain Proteins | 3 | 2022 | 268 | 0.250 |
Why?
|
| NAV1.4 Voltage-Gated Sodium Channel | 2 | 2015 | 2 | 0.230 |
Why?
|
| Sodium | 3 | 2015 | 62 | 0.230 |
Why?
|
| Cytoplasm | 4 | 2014 | 275 | 0.220 |
Why?
|
| RNA, Messenger | 5 | 2018 | 1537 | 0.220 |
Why?
|
| Canavan Disease | 1 | 2023 | 11 | 0.200 |
Why?
|
| Inclusion Bodies | 2 | 2016 | 14 | 0.200 |
Why?
|
| Heart | 2 | 2023 | 283 | 0.200 |
Why?
|
| Heart Rate | 1 | 2023 | 322 | 0.190 |
Why?
|
| Myoblasts | 1 | 2022 | 64 | 0.180 |
Why?
|
| Cell Line | 6 | 2022 | 2040 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 148 | 0.170 |
Why?
|
| Neurons | 3 | 2018 | 922 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2002 | 248 | 0.150 |
Why?
|
| Mice, Transgenic | 7 | 2016 | 1277 | 0.150 |
Why?
|
| Golgi Apparatus | 1 | 2019 | 64 | 0.150 |
Why?
|
| Spinal Cord | 5 | 2016 | 204 | 0.150 |
Why?
|
| Dyneins | 3 | 2008 | 111 | 0.150 |
Why?
|
| Mutant Proteins | 2 | 2009 | 105 | 0.150 |
Why?
|
| Calcium | 2 | 2020 | 575 | 0.140 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 173 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 1198 | 0.140 |
Why?
|
| Protein Structure, Secondary | 6 | 2008 | 260 | 0.140 |
Why?
|
| Cells, Cultured | 6 | 2022 | 2157 | 0.140 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 40 | 0.140 |
Why?
|
| Bevacizumab | 1 | 2017 | 59 | 0.130 |
Why?
|
| Recombinant Proteins | 5 | 2008 | 702 | 0.130 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 87 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2018 | 154 | 0.130 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 319 | 0.130 |
Why?
|
| Kinetics | 5 | 2008 | 763 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2017 | 201 | 0.130 |
Why?
|
| Trans-Activators | 2 | 2011 | 311 | 0.130 |
Why?
|
| Muscles | 2 | 1988 | 179 | 0.120 |
Why?
|
| Binding Sites | 5 | 2009 | 904 | 0.120 |
Why?
|
| Diaphragm | 1 | 2015 | 22 | 0.120 |
Why?
|
| Actins | 2 | 1988 | 259 | 0.120 |
Why?
|
| Mass Spectrometry | 4 | 2013 | 301 | 0.120 |
Why?
|
| Computational Biology | 1 | 2017 | 356 | 0.120 |
Why?
|
| Models, Molecular | 6 | 2009 | 1149 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2008 | 326 | 0.110 |
Why?
|
| Protein Conformation | 5 | 2009 | 779 | 0.110 |
Why?
|
| Cysteine | 2 | 2007 | 108 | 0.110 |
Why?
|
| Dithiothreitol | 2 | 2005 | 18 | 0.110 |
Why?
|
| Electrophysiology | 3 | 2008 | 89 | 0.110 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2014 | 35 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2009 | 383 | 0.110 |
Why?
|
| DNA Helicases | 2 | 2016 | 190 | 0.110 |
Why?
|
| Middle Aged | 3 | 2024 | 17612 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 448 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 33 | 0.100 |
Why?
|
| Patents as Topic | 1 | 2012 | 7 | 0.100 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 72 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 149 | 0.100 |
Why?
|
| Potassium Channels | 1 | 2012 | 58 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2014 | 346 | 0.100 |
Why?
|
| Transfection | 5 | 2008 | 694 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 707 | 0.090 |
Why?
|
| Monensin | 1 | 2011 | 4 | 0.090 |
Why?
|
| Capsaicin | 1 | 2011 | 18 | 0.090 |
Why?
|
| Albuterol | 1 | 2011 | 24 | 0.090 |
Why?
|
| Cell Lineage | 2 | 2023 | 270 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2009 | 115 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2011 | 139 | 0.090 |
Why?
|
| Cell Nucleus | 4 | 2018 | 629 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 2186 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2010 | 298 | 0.080 |
Why?
|
| Male | 4 | 2024 | 29897 | 0.080 |
Why?
|
| Phenotype | 3 | 2008 | 1206 | 0.080 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 2009 | 2 | 0.080 |
Why?
|
| Holoenzymes | 1 | 2009 | 3 | 0.080 |
Why?
|
| Titrimetry | 1 | 2009 | 11 | 0.080 |
Why?
|
| Electrophoresis | 1 | 2009 | 16 | 0.080 |
Why?
|
| Crystallography, X-Ray | 6 | 2008 | 433 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 367 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 1148 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1469 | 0.070 |
Why?
|
| Detergents | 1 | 2008 | 34 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 458 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 1617 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 143 | 0.070 |
Why?
|
| Zebrafish | 1 | 2010 | 347 | 0.070 |
Why?
|
| Action Potentials | 2 | 2015 | 105 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 441 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 81 | 0.060 |
Why?
|
| Enzyme Stability | 2 | 2007 | 47 | 0.060 |
Why?
|
| Protein Folding | 1 | 2008 | 267 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 1997 | 191 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 560 | 0.060 |
Why?
|
| Calorimetry, Differential Scanning | 2 | 2005 | 31 | 0.060 |
Why?
|
| Membrane Potentials | 2 | 2015 | 141 | 0.060 |
Why?
|
| Genes | 1 | 1986 | 90 | 0.060 |
Why?
|
| Adult | 5 | 2024 | 16824 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 383 | 0.060 |
Why?
|
| Histidine | 1 | 2005 | 34 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 1 | 2005 | 100 | 0.060 |
Why?
|
| Female | 6 | 2024 | 32882 | 0.060 |
Why?
|
| Arginine | 1 | 2005 | 124 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 99 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2024 | 50 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 172 | 0.050 |
Why?
|
| Disease Progression | 1 | 2008 | 1172 | 0.050 |
Why?
|
| Pyridines | 1 | 2024 | 111 | 0.050 |
Why?
|
| Molecular Weight | 3 | 2008 | 187 | 0.050 |
Why?
|
| RNA Helicases | 2 | 2016 | 94 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2023 | 36 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2003 | 16 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2023 | 37 | 0.050 |
Why?
|
| Iodoacetamide | 1 | 2002 | 3 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 78 | 0.050 |
Why?
|
| Rats | 2 | 1997 | 1981 | 0.050 |
Why?
|
| Proteomics | 2 | 2019 | 283 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2024 | 739 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2002 | 195 | 0.050 |
Why?
|
| Aging | 1 | 2008 | 745 | 0.050 |
Why?
|
| PAX3 Transcription Factor | 1 | 2022 | 12 | 0.050 |
Why?
|
| Insecta | 1 | 2002 | 37 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2002 | 67 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2022 | 26 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 218 | 0.050 |
Why?
|
| Protein Engineering | 1 | 2002 | 82 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2002 | 196 | 0.040 |
Why?
|
| DNA Primers | 1 | 2002 | 293 | 0.040 |
Why?
|
| Muscle Development | 1 | 2022 | 54 | 0.040 |
Why?
|
| Regeneration | 1 | 2022 | 95 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1353 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 94 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 197 | 0.040 |
Why?
|
| Temperature | 2 | 2004 | 307 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2022 | 288 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 385 | 0.040 |
Why?
|
| Coat Protein Complex I | 1 | 2019 | 5 | 0.040 |
Why?
|
| Arsenites | 1 | 2019 | 7 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 2019 | 53 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cytochrome b Group | 1 | 1998 | 20 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 517 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2009 | 3034 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 32 | 0.040 |
Why?
|
| Protein Binding | 3 | 2009 | 1603 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1186 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 1998 | 87 | 0.040 |
Why?
|
| Models, Biological | 2 | 2009 | 1180 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 168 | 0.040 |
Why?
|
| Epirubicin | 1 | 2017 | 4 | 0.030 |
Why?
|
| Isoleucine | 1 | 1997 | 9 | 0.030 |
Why?
|
| Valine | 1 | 1997 | 32 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 73 | 0.030 |
Why?
|
| Hyperkalemia | 1 | 1997 | 20 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2017 | 66 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 82 | 0.030 |
Why?
|
| Remission Induction | 1 | 2017 | 148 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1988 | 98 | 0.030 |
Why?
|
| Nurse Specialists | 1 | 2017 | 1 | 0.030 |
Why?
|
| Malawi | 1 | 2017 | 11 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 17 | 0.030 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2017 | 8 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 536 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2018 | 144 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2017 | 19 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1997 | 45 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2013 | 936 | 0.030 |
Why?
|
| Oncology Nursing | 1 | 2017 | 16 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1997 | 89 | 0.030 |
Why?
|
| Health Planning | 1 | 2017 | 32 | 0.030 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2016 | 5 | 0.030 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2016 | 9 | 0.030 |
Why?
|
| Plasmids | 2 | 2008 | 292 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1996 | 39 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1997 | 153 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1996 | 130 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2008 | 166 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2017 | 120 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 400 | 0.030 |
Why?
|
| COS Cells | 2 | 2007 | 175 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2017 | 199 | 0.030 |
Why?
|
| Horse Diseases | 1 | 1995 | 20 | 0.030 |
Why?
|
| Education, Medical | 1 | 2017 | 184 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2017 | 337 | 0.030 |
Why?
|
| Horses | 2 | 2008 | 52 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 2004 | 160 | 0.030 |
Why?
|
| Dimerization | 2 | 2004 | 145 | 0.030 |
Why?
|
| Decapodiformes | 1 | 2013 | 14 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2024 | 5684 | 0.030 |
Why?
|
| Myosins | 1 | 2014 | 114 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2013 | 76 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2014 | 292 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 921 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 199 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 673 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2013 | 162 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 1592 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 481 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1991 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 896 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 359 | 0.020 |
Why?
|
| Adolescent | 1 | 2022 | 6245 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 622 | 0.020 |
Why?
|
| Base Sequence | 2 | 1998 | 1331 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 676 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 489 | 0.020 |
Why?
|
| Thyroglobulin | 1 | 2008 | 9 | 0.020 |
Why?
|
| Static Electricity | 1 | 2009 | 167 | 0.020 |
Why?
|
| Solvents | 1 | 2008 | 58 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2008 | 47 | 0.020 |
Why?
|
| Dynactin Complex | 1 | 2008 | 6 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 1988 | 21 | 0.020 |
Why?
|
| Cell Fusion | 1 | 1988 | 37 | 0.020 |
Why?
|
| tau Proteins | 1 | 2009 | 201 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1988 | 36 | 0.020 |
Why?
|
| Chromatin | 1 | 2013 | 608 | 0.020 |
Why?
|
| Chickens | 1 | 1988 | 95 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 310 | 0.020 |
Why?
|
| Dipeptides | 1 | 1988 | 67 | 0.020 |
Why?
|
| Synapses | 1 | 2009 | 184 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 257 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 297 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 180 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 131 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2007 | 48 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2007 | 38 | 0.020 |
Why?
|
| Cell Division | 1 | 1988 | 450 | 0.020 |
Why?
|
| Serine | 1 | 2007 | 91 | 0.020 |
Why?
|
| Axons | 1 | 2007 | 123 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1986 | 44 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 34 | 0.020 |
Why?
|
| Transition Temperature | 1 | 2005 | 6 | 0.010 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2005 | 19 | 0.010 |
Why?
|
| Smad2 Protein | 1 | 2004 | 8 | 0.010 |
Why?
|
| Smad3 Protein | 1 | 2004 | 17 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 133 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 2004 | 73 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2004 | 130 | 0.010 |
Why?
|
| Algorithms | 1 | 2008 | 1003 | 0.010 |
Why?
|
| Amyloid | 1 | 2003 | 70 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2003 | 139 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 381 | 0.010 |
Why?
|
| Water | 1 | 2003 | 309 | 0.010 |
Why?
|
| Polymers | 1 | 2004 | 325 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 507 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1986 | 879 | 0.010 |
Why?
|
| Coenzymes | 1 | 1998 | 7 | 0.010 |
Why?
|
| Electron Transport Complex III | 1 | 1998 | 5 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1998 | 15 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1998 | 25 | 0.010 |
Why?
|
| Ubiquinone | 1 | 1998 | 18 | 0.010 |
Why?
|
| Folic Acid | 1 | 1998 | 41 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 173 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 93 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 363 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 299 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 294 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 3396 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 16 | 0.010 |
Why?
|
| Family Health | 1 | 1996 | 69 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 1998 | 322 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1996 | 415 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1995 | 260 | 0.010 |
Why?
|
| Exercise | 1 | 1998 | 942 | 0.010 |
Why?
|
| Child | 1 | 1997 | 4526 | 0.000 |
Why?
|
| Time Factors | 1 | 1995 | 3771 | 0.000 |
Why?
|